ES2192556T3 - Mejoras en o relativas a la vacuna de la malaria. - Google Patents

Mejoras en o relativas a la vacuna de la malaria.

Info

Publication number
ES2192556T3
ES2192556T3 ES93904239T ES93904239T ES2192556T3 ES 2192556 T3 ES2192556 T3 ES 2192556T3 ES 93904239 T ES93904239 T ES 93904239T ES 93904239 T ES93904239 T ES 93904239T ES 2192556 T3 ES2192556 T3 ES 2192556T3
Authority
ES
Spain
Prior art keywords
sequences
relating
polypeptides
malaria vaccine
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93904239T
Other languages
English (en)
Inventor
Anthony Arthur Holder
Michael John Blackman
Jonathan Andrew Chappel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Application granted granted Critical
Publication of ES2192556T3 publication Critical patent/ES2192556T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE PRESENTAN NUEVOS POLIPEPTIDOS QUE CONTIENEN SUSTANCIALMENTE LAS SECUENCIAS MOSTRADAS EN LAS FIGURAS 1 Y 2, AISLADOS DE LAS SECUENCIAS QUE OCURREN DE FORMA NATURAL ADYACENTES A LAS MISMAS DE LA PROTEINA SE SUPERFICIE MEROZOIDE MSP1. TAMBIEN SE PRESENTAN LOS VECTORES QUE CONTIENEN SECUENCIAS DE NUCLEOTIDOS QUE CODIFICAN DICHOS POLIPEPTIDOS, LAS CELULAS HUESPEDES QUE CONTIENEN DICHOS VECTORES Y UNA VACUNA QUE CONTIENE UNO O LOS DOS POLIPEPTIDOS NUEVOS.
ES93904239T 1992-02-22 1993-02-22 Mejoras en o relativas a la vacuna de la malaria. Expired - Lifetime ES2192556T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203821A GB9203821D0 (en) 1992-02-22 1992-02-22 Improvements in or relating to malaria vaccine

Publications (1)

Publication Number Publication Date
ES2192556T3 true ES2192556T3 (es) 2003-10-16

Family

ID=10710868

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93904239T Expired - Lifetime ES2192556T3 (es) 1992-02-22 1993-02-22 Mejoras en o relativas a la vacuna de la malaria.

Country Status (13)

Country Link
US (1) US5720959A (es)
EP (1) EP0627004B1 (es)
JP (1) JPH07504321A (es)
KR (1) KR100262624B1 (es)
AT (1) ATE231555T1 (es)
AU (1) AU666519B2 (es)
CA (1) CA2128109C (es)
DE (1) DE69332652T2 (es)
DK (1) DK0627004T3 (es)
ES (1) ES2192556T3 (es)
GB (1) GB9203821D0 (es)
NZ (1) NZ249208A (es)
WO (1) WO1993017107A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697022B1 (fr) 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
FR2744724B1 (fr) 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
US6828416B1 (en) 1998-08-21 2004-12-07 The United States Of America As Represented By The Department Of Health And Human Services Recombinant multivalent malarial vaccine against Plasmodium falciparum
AU1600401A (en) 1999-11-12 2001-06-06 Chinese University Of Hong Kong, The Malaria vaccine
CN1176945C (zh) * 2001-02-01 2004-11-24 中国人民解放军第二军医大学 疟原虫融合抗原及其制法和用途
US20030104003A1 (en) * 2001-05-25 2003-06-05 James Anthony A. Novel surface protein of the malaria parasite plasmodium falciparum
WO2006124712A2 (en) * 2005-05-16 2006-11-23 Merck & Co., Inc. A method for improving the immunogenicity of plasmodium antigens
US7931908B2 (en) * 2007-02-23 2011-04-26 Philadelphia Health Education Corporation Chimeric MSP-based malaria vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3280028D1 (en) * 1981-05-21 1989-12-28 Wellcome Found Protozoal antigen

Also Published As

Publication number Publication date
CA2128109A1 (en) 1993-09-02
KR950700415A (ko) 1995-01-16
WO1993017107A1 (en) 1993-09-02
EP0627004B1 (en) 2003-01-22
AU666519B2 (en) 1996-02-15
DE69332652D1 (de) 2003-02-27
AU3570493A (en) 1993-09-13
NZ249208A (en) 1996-03-26
JPH07504321A (ja) 1995-05-18
DK0627004T3 (da) 2003-05-12
ATE231555T1 (de) 2003-02-15
GB9203821D0 (en) 1992-04-08
KR100262624B1 (ko) 2000-08-01
EP0627004A1 (en) 1994-12-07
DE69332652T2 (de) 2003-11-27
CA2128109C (en) 2007-09-25
US5720959A (en) 1998-02-24

Similar Documents

Publication Publication Date Title
FI954534A7 (fi) Heterologisten polypeptiidien ilmentyminen halobakteereissa
DK97790A (da) Renin-inhiberende peptider
FI932722L (fi) Glukagonlika peptider och insulinotropinderivat
DE69319679D1 (de) Eingabe von Sonderbuchstaben
IT1184832B (it) Procedimento di tintura di cuoi naturali
DK499886A (da) Peptid
DK197989A (da) Peptidanaloger
DE69408874D1 (de) Reinigung von erdgas
FI904852A7 (fi) Antikoagulanttipeptidit
ES2146193T1 (es) Proteinas del virus del arrugado de las hojas de la vid (tipo 2) y sus usos.
FI895844A7 (fi) Hyytymistä estävät peptidit
KR900700503A (ko) 펩티드
IT1190237B (it) Compressore contrifugo del tipo a pompa di reintegro e stadio di riciclaggio
FI942467A0 (fi) Proteesivakaat proteiinit
IT8519513A0 (it) Protesi di capelli
NO177858C (no) Peptid
FI901773A7 (fi) Vasoaktiiviset peptidit
DE3685802D1 (de) Verwendung von perfluorpolyaethern in mechanischen pumpen.
KR890017019U (ko) 지 갑
DE69325271D1 (de) Hydrosilylierung von fullarenen
KR900000163U (ko) 눈 화장용 케이스
IT8543517A0 (it) L'autorotante di newton e di archimede
ITMI922675A1 (it) Peptidi immunogenici
LV5812A4 (lv) Polipeptida iegusanas panemiens ekspresijas vektors un dns secibas
KR910015000U (ko) 화장품 용기의 펌핑부재